MEDERA’S SARDOCOR ANNOUNCES FDA CLEARANCE OF IND FOR FIRST-IN-HUMAN GENE THERAPY CLINICAL TRIAL FOR DMD CARDIOMYOPATHY
EINPresswire,
BOSTON, MASSACHUSETTS, UNITED STATES, December 1, 2022 / • With modern therapeutic strategies to prolong life expectancy, an…